What question did this study set out to answer?

The research aims to explore the role of acyloxyacyl hydrolase in Alzheimer's disease and its impact on LPS detoxification and neuroinflammation.

February 2, 2026MoleculesOpen Access

Down-Regulation of Acyloxyacyl Hydrolase Expression in Alzheimer’s Disease Impairs LPS Detoxification and Contributes to Brain Pro-Inflammatory Signaling

View Full Paper

Ask AI

Bookmark

Authors

Shows reduced acyloxyacyl hydrolase expression impairs LPS detoxification in Alzheimer's disease, suggesting a link to neuroinflammation.

The research aims to explore the role of acyloxyacyl hydrolase in Alzheimer's disease and its impact on LPS detoxification and neuroinflammation.
Analyzed brain tissue from Alzheimer's disease patients for AOAH expression levels.
Measured microRNA levels, particularly hsa-miR-450b-5p, associated with AOAH regulation.
Conducted luciferase reporter assays to assess miR-450b-5p's targeting of AOAH.
Performed in vitro experiments on human neuronal glial cells to confirm AOAH expression changes.
Found reduced AOAH mRNA levels in Alzheimer's disease brains.
Noted elevated hsa-miR-450b-5p levels correlating with reduced AOAH expression.
Demonstrated miR-450b-5p directly targets AOAH, suppressing its activity through reporter assays.
Confirmed down-regulation of AOAH protein levels in human neuronal glial cells.

Zhao et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark